My Post-FDA Over-The-Weekend Watchlist:
$GLYC
$ONCT
$ONCY
$PIRS
$AGEN
All of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is likely that we see a gap up on Monday and a solid downtrend from there. Like and follow for more biotech ideas like this :) Happy Trading!
Remember that these are biotech stocks and there are no guarantees in this sector. Proceed with caution!
$GLYC
$ONCT
$ONCY
$PIRS
$AGEN
All of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is likely that we see a gap up on Monday and a solid downtrend from there. Like and follow for more biotech ideas like this :) Happy Trading!
Remember that these are biotech stocks and there are no guarantees in this sector. Proceed with caution!
